V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210030555 | 210010651 | 1.64 | 104.4 | Palliative (P) | null | 2016-06-05 | Temozolomide + RT | 2 | N | 210025280 | TEMOZOLOMIDE + RT |
| 210030557 | 210010662 | null | 86.4 | Adjuvant (A) | null | 2016-09-01 | Trial Unspecified | N | null | 210025401 | TRIAL |
| 210030558 | 210033363 | null | 91.2 | Palliative (P) | 2015-08-07 | 2015-08-13 | Trial Unspecified | 01 | null | 210025439 | TRIAL |
| 210030559 | 210010671 | 0 | 63.7 | Disease modification (D) | 2016-12-14 | 2017-02-10 | Temozolomide + RT | N | null | 210025489 | TEMOZOLOMIDE + RT |
| 210030560 | 210020934 | 1.6 | 118.4 | Palliative (P) | 2019-04-23 | 2019-04-23 | CNS Medbl HR Cyclo+Vinc | Y | N | 210025499 | TRIAL |
| 210030561 | 210010680 | 1.53 | 59.2 | Palliative (P) | 2013-06-28 | 2013-08-13 | Temozolomide + RT | 2 | null | 210025559 | TEMOZOLOMIDE + RT |
| 210030562 | 210010682 | 1.64 | 71.3 | Palliative (P) | 2014-10-04 | 2016-02-01 | Trial Unspecified | null | Y | 210025568 | TRIAL |
| 210030563 | 210010684 | null | 85 | Palliative (P) | 2016-12-14 | 2016-11-20 | Temozolomide + RT | 2 | null | 210025630 | TEMOZOLOMIDE + RT |
| 210030564 | 210010689 | 1.78 | null | Curative (C) | 2017-05-17 | 2017-06-08 | Temozolomide + RT | N | N | 210025660 | TEMOZOLOMIDE + RT |
| 210030565 | 210010697 | null | 64.5 | Curative (C) | null | 2016-02-19 | Temozolomide + RT | N | 0 | 210025775 | TEMOZOLOMIDE + RT |
| 210030566 | 210033368 | 1.49 | 84.1 | Curative (C) | 2018-04-02 | 2018-04-09 | ESPHALL TRIAL | N | N | 210025796 | TRIAL |
| 210030567 | 210027247 | 1.79 | 66.5 | Palliative (P) | 2013-10-20 | 2013-11-04 | Temozolomide + RT | N | N | 210025802 | TEMOZOLOMIDE + RT |
| 210030568 | 210010707 | 1.63 | 75.7 | Curative (C) | 2014-09-11 | 2014-09-15 | Trial Unspecified | 01 | N | 210025884 | TRIAL |
| 210030569 | 210020979 | 1.8 | 38.3 | Curative (C) | 2017-02-12 | 2017-02-23 | Trial Unspecified | N | N | 210026347 | TRIAL |
| 210030570 | 210010736 | 1.63 | 47.4 | Disease modification (D) | 2019-03-07 | 2019-03-08 | Trial Unspecified | N | N | 210026367 | TRIAL |
| 210030571 | 210027256 | null | 59.2 | Curative (C) | null | 2014-05-30 | Temozolomide + RT | N | N | 210026390 | TEMOZOLOMIDE + RT |
| 210030572 | 210010739 | 1.85 | 73.6 | Palliative (P) | 2019-09-05 | 2019-09-05 | Trial Unspecified | Y | N | 210026399 | TRIAL |
| 210030573 | 210010743 | 1.86 | 77.2 | Disease modification (D) | 2016-12-10 | 2017-01-20 | Temozolomide + RT | null | N | 210026489 | TEMOZOLOMIDE + RT |
| 210030574 | 210034970 | 1.19 | null | Not known (9) | 2015-10-10 | 2015-11-04 | Temozolomide + RT | N | Y | 210026541 | TEMOZOLOMIDE + RT |
| 210030575 | 210010748 | 1.72 | 65.4 | Curative (C) | 2016-09-17 | 2016-09-17 | Temozolomide + RT | N | N | 210026580 | TEMOZOLOMIDE + RT |
| 210030576 | 210010750 | 1.8 | 74.4 | Palliative (P) | 2016-11-14 | 2016-11-14 | Trial Unspecified | 01 | N | 210026586 | TRIAL |
| 210030577 | 210010755 | 1.84 | null | Curative (C) | 2014-10-28 | 2014-10-28 | Trial Unspecified | Y | N | 210026623 | TRIAL |
| 210030578 | 210034972 | 1.19 | 64 | null | 2017-07-09 | 2017-08-15 | Temozolomide + RT | 02 | null | 210026635 | TEMOZOLOMIDE + RT |
| 210030579 | 210020996 | 1.64 | 68.4 | Disease modification (D) | 2015-06-26 | 2015-06-27 | Trial Unspecified | null | null | 210026637 | TRIAL |
| 210030580 | 210010759 | null | null | Adjuvant (A) | 2017-08-16 | 2017-08-16 | Temozolomide + RT | 02 | N | 210026643 | TEMOZOLOMIDE + RT |
| 210030581 | 210027264 | 1.67 | 77.2 | Disease modification (D) | 2016-03-19 | 2016-03-19 | Trial Unspecified | N | N | 210026670 | TRIAL |
| 210030582 | 210010772 | null | 24.9 | Adjuvant (A) | 2017-03-16 | 2017-04-11 | Temozolomide + RT | N | N | 210026842 | TEMOZOLOMIDE + RT |
| 210030583 | 210010775 | 0 | 0 | Palliative (P) | 2017-11-06 | 2017-11-13 | Trial Unspecified | Y | N | 210026869 | TRIAL |
| 210030584 | 210010779 | 1.86 | 81.95 | Disease modification (D) | 2016-05-19 | 2016-07-03 | Trial Unspecified | Y | N | 210026889 | TRIAL |
| 210030585 | 210010782 | 1.16 | null | Unknown (U) | 2019-01-14 | 2019-02-19 | Trial Unspecified | N | N | 210026910 | TRIAL |
| 210030586 | 210010784 | 1.76 | 47.4 | Disease modification (D) | 2018-01-29 | 2019-02-12 | CNS HGG HERBY Bevacizumab | 02 | N | 210026919 | TRIAL |
| 210030587 | 210010787 | 1.63 | 88.9 | Palliative (P) | 2015-05-21 | 2015-06-05 | Temozolomide + RT | N | N | 210026938 | TEMOZOLOMIDE + RT |
| 210030588 | 210010790 | 1.64 | null | Palliative (P) | 2014-04-08 | 2014-04-14 | Trial Unspecified | Y | N | 210026957 | TRIAL |
| 210030589 | 210010793 | 1.65 | 77.6 | Palliative (P) | 2014-01-18 | 2014-02-22 | Trial Unspecified | Y | Y | 210026998 | TRIAL |
| 210030590 | 210010796 | null | 80.8 | Curative (C) | 2014-06-09 | 2014-08-24 | Temozolomide + RT | 2 | N | 210027027 | TEMOZOLOMIDE + RT |
| 210030591 | 210010800 | null | 52.7 | Adjuvant (A) | 2016-08-17 | 2016-08-26 | Trial Unspecified | N | N | 210027028 | TRIAL |
| 210030592 | 210010803 | null | 85.2 | Disease modification (D) | 2015-11-29 | 2015-12-02 | ESPHALL TRIAL | Y | null | 210027036 | TRIAL |
| 210030593 | 210010809 | 1.76 | 49.5 | Disease modification (D) | 2014-06-13 | 2014-07-24 | Temozolomide + RT | N | N | 210027055 | TEMOZOLOMIDE + RT |
| 210030594 | 210010810 | 1.8 | null | Curative (C) | 2017-09-17 | 2017-09-17 | Trial Unspecified | N | N | 210027080 | TRIAL |
| 210030595 | 210010811 | 1.72 | 72 | Curative (C) | 2015-01-01 | 2015-05-20 | Trial Unspecified | N | null | 210027083 | TRIAL |
| 210030596 | 210010812 | null | 65.4 | Palliative (P) | 2017-09-03 | 2017-09-14 | Temozolomide + RT | 02 | null | 210027099 | TEMOZOLOMIDE + RT |
| 210030597 | 210027288 | null | 63 | Curative (C) | 2015-05-21 | 2015-06-24 | Temozolomide + RT | N | null | 210027114 | TEMOZOLOMIDE + RT |
| 210030598 | 210010816 | 1.6 | 79 | null | 2014-04-17 | 2014-05-07 | Temozolomide + RT | N | null | 210027124 | TEMOZOLOMIDE + RT |
| 210030599 | 210010822 | 1.78 | 82.4 | Curative (C) | 2017-03-12 | 2017-03-17 | Trial Unspecified | 1 | Y | 210027159 | TRIAL |
| 210030600 | 210010823 | 1.75 | 109.6 | Palliative (P) | 2016-06-07 | 2016-06-24 | Temozolomide + RT | N | N | 210027183 | TEMOZOLOMIDE + RT |
| 210030601 | 210010825 | 1.8 | 65.4 | Adjuvant (A) | 2014-05-10 | 2014-06-07 | Temozolomide + RT | 02 | N | 210027184 | TEMOZOLOMIDE + RT |
| 210030602 | 210010829 | 1.81 | null | Curative (C) | 2018-02-15 | 2018-03-26 | Trial Unspecified | Y | Y | 210027205 | TRIAL |
| 210030603 | 210010846 | null | 111 | Disease modification (D) | 2017-12-18 | 2018-02-26 | Temozolomide + RT | 02 | N | 210027322 | TEMOZOLOMIDE + RT |
| 210030604 | 210010850 | 1.7 | null | Neo-adjuvant (N) | 2013-12-18 | 2014-01-09 | ESPHALL TRIAL | Y | N | 210027335 | TRIAL |
| 210030605 | 210010857 | null | 55.8 | Palliative (P) | 2017-10-27 | 2017-11-24 | Temozolomide + RT | 02 | N | 210027382 | TEMOZOLOMIDE + RT |